N

North China Pharmaceutical Co Ltd
SSE:600812

Watchlist Manager
North China Pharmaceutical Co Ltd
SSE:600812
Watchlist
Price: 5.56 CNY -1.07% Market Closed
Market Cap: 9.5B CNY

Intrinsic Value

The intrinsic value of one North China Pharmaceutical Co Ltd stock under the Base Case scenario is 6.85 CNY. Compared to the current market price of 5.56 CNY, North China Pharmaceutical Co Ltd is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6.85 CNY
Undervaluation 19%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
North China Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about North China Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is North China Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for North China Pharmaceutical Co Ltd.

Explain Valuation
Compare North China Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about North China Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
North China Pharmaceutical Co Ltd

Current Assets 8.3B
Receivables 4.2B
Other Current Assets 4.2B
Non-Current Assets 13.2B
Long-Term Investments 1.2B
PP&E 7B
Intangibles 4.9B
Other Non-Current Assets 131m
Current Liabilities 12.4B
Accounts Payable 2.2B
Accrued Liabilities 206m
Short-Term Debt 6.6B
Other Current Liabilities 3.4B
Non-Current Liabilities 3.6B
Long-Term Debt 2.3B
Other Non-Current Liabilities 1.3B
Efficiency

Free Cash Flow Analysis
North China Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
North China Pharmaceutical Co Ltd

Revenue
9.8B CNY
Cost of Revenue
-6.9B CNY
Gross Profit
2.9B CNY
Operating Expenses
-2.3B CNY
Operating Income
681.8m CNY
Other Expenses
-498.8m CNY
Net Income
183m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

North China Pharmaceutical Co Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
ROE is Increasing
ROIC is Increasing
43/100
Profitability
Score

North China Pharmaceutical Co Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

North China Pharmaceutical Co Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Low Altman Z-Score
42/100
Solvency
Score

North China Pharmaceutical Co Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
North China Pharmaceutical Co Ltd

There are no price targets for North China Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for North China Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one North China Pharmaceutical Co Ltd stock?

The intrinsic value of one North China Pharmaceutical Co Ltd stock under the Base Case scenario is 6.85 CNY.

Is North China Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5.56 CNY, North China Pharmaceutical Co Ltd is Undervalued by 19%.

Back to Top